Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection.

Gulick RM, Ribaudo HJ, Shikuma CM, Lustgarten S, Squires KE, Meyer WA, Acosta EP, Schackman BR, Pilcher CD, Murphy RL, Maher WE, Witt MD, Reichman RC, Snyder S, Klingman KL, Kuritzkes DR. Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection. N Engl J Med. 2004 Apr 29; 350(18):1850-61.

View in: PubMed

subject areas

Adult
Aged
Alkynes
Benzoxazines
CD4 Lymphocyte Count
Cyclopropanes
Dideoxynucleosides
Double-Blind Method
Drug Resistance, Viral
Drug Therapy, Combination
Female
Follow-Up Studies
HIV Infections
HIV-1
Humans
Lamivudine
Male
Middle Aged
Nucleosides
Oxazines
Reverse Transcriptase Inhibitors
RNA, Viral
Zidovudine

authors with profiles

Cecilia M. Shikuma,MD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support